| gene silencing by mirna | GO:0035195 | 10 | 0.577 | |
| histone methylation | GO:0016571 | 71 | 0.506 | |
| chromatin organization | GO:0006325 | 206 | 0.419 | |
| histone lysine methylation | GO:0034968 | 50 | 0.310 | |
| chromatin modification | GO:0016568 | 187 | 0.232 | |
| protein methylation | GO:0006479 | 81 | 0.229 | |
| peptidyl lysine modification | GO:0018205 | 77 | 0.210 | |
| histone modification | GO:0016570 | 159 | 0.125 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.112 | |
| histone acetylation | GO:0016573 | 41 | 0.108 | |
| methylation | GO:0032259 | 134 | 0.097 | |
| covalent chromatin modification | GO:0016569 | 163 | 0.093 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.089 | |
| digestive tract development | GO:0048565 | 190 | 0.075 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.073 | |
| cellular macromolecule catabolic process | GO:0044265 | 206 | 0.072 | |
| dna metabolic process | GO:0006259 | 303 | 0.070 | |
| digestive system development | GO:0055123 | 200 | 0.070 | |
| macromolecule methylation | GO:0043414 | 120 | 0.069 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.063 | |
| amine metabolic process | GO:0009308 | 45 | 0.061 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.058 | |
| embryonic hemopoiesis | GO:0035162 | 23 | 0.057 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.056 | |
| rna processing | GO:0006396 | 105 | 0.055 | |
| t cell activation | GO:0042110 | 289 | 0.055 | |
| cytokine production | GO:0001816 | 319 | 0.055 | |
| gene silencing by rna | GO:0031047 | 19 | 0.055 | |
| digestive tract morphogenesis | GO:0048546 | 147 | 0.053 | |
| regulation of defense response | GO:0031347 | 233 | 0.053 | |
| mrna metabolic process | GO:0016071 | 84 | 0.052 | |
| gene silencing | GO:0016458 | 38 | 0.052 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.052 | |
| posttranscriptional gene silencing | GO:0016441 | 10 | 0.052 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.051 | |
| peptidyl lysine methylation | GO:0018022 | 29 | 0.051 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.050 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.049 | |
| posttranscriptional gene silencing by rna | GO:0035194 | 10 | 0.049 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.049 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.048 | |
| glucose metabolic process | GO:0006006 | 92 | 0.046 | |
| regionalization | GO:0003002 | 337 | 0.044 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.044 | |
| histone h3 k4 trimethylation | GO:0080182 | 5 | 0.044 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.044 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.042 | |
| establishment or maintenance of cell polarity | GO:0007163 | 86 | 0.042 | |
| renal system development | GO:0072001 | 225 | 0.040 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.040 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.040 | |
| dna alkylation | GO:0006305 | 43 | 0.039 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.039 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.037 | |
| gtp metabolic process | GO:0046039 | 144 | 0.036 | |
| internal protein amino acid acetylation | GO:0006475 | 42 | 0.036 | |
| cellular response to dna damage stimulus | GO:0006974 | 207 | 0.036 | |
| homeostasis of number of cells | GO:0048872 | 210 | 0.036 | |
| carbohydrate metabolic process | GO:0005975 | 230 | 0.036 | |
| negative regulation of immune system process | GO:0002683 | 209 | 0.036 | |
| urogenital system development | GO:0001655 | 261 | 0.035 | |
| protein acylation | GO:0043543 | 64 | 0.035 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.035 | |
| muscle tissue development | GO:0060537 | 308 | 0.035 | |
| gastrulation | GO:0007369 | 116 | 0.035 | |
| histone h3 k4 methylation | GO:0051568 | 23 | 0.034 | |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.033 | |
| skeletal system development | GO:0001501 | 356 | 0.033 | |
| internal peptidyl lysine acetylation | GO:0018393 | 42 | 0.033 | |
| protein modification by small protein conjugation or removal | GO:0070647 | 207 | 0.033 | |
| regulation of transcription from rna polymerase iii promoter | GO:0006359 | 2 | 0.032 | |
| protein catabolic process | GO:0030163 | 221 | 0.032 | |
| stem cell differentiation | GO:0048863 | 268 | 0.031 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.031 | |
| peptidyl lysine acetylation | GO:0018394 | 45 | 0.031 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.031 | |
| protein alkylation | GO:0008213 | 81 | 0.030 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.030 | |
| regulation of cytokine production | GO:0001817 | 266 | 0.030 | |
| ossification | GO:0001503 | 216 | 0.030 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.030 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.029 | |
| dna modification | GO:0006304 | 50 | 0.029 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.028 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.027 | |
| glucose homeostasis | GO:0042593 | 128 | 0.027 | |
| t cell differentiation | GO:0030217 | 174 | 0.027 | |
| rna splicing | GO:0008380 | 54 | 0.027 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.026 | |
| nucleotide catabolic process | GO:0009166 | 217 | 0.026 | |
| kidney development | GO:0001822 | 213 | 0.026 | |
| positive regulation of dna templated transcription elongation | GO:0032786 | 2 | 0.026 | |
| stem cell maintenance | GO:0019827 | 130 | 0.025 | |
| positive regulation of t cell anergy | GO:0002669 | 4 | 0.025 | |
| protein targeting | GO:0006605 | 143 | 0.025 | |
| endoderm formation | GO:0001706 | 20 | 0.024 | |
| oxidation reduction process | GO:0055114 | 342 | 0.024 | |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.024 | |
| regulation of organ morphogenesis | GO:2000027 | 144 | 0.023 | |
| epithalamus development | GO:0021538 | 2 | 0.022 | |
| endoderm development | GO:0007492 | 45 | 0.022 | |
| carbohydrate homeostasis | GO:0033500 | 128 | 0.022 | |
| regulation of lymphocyte activation | GO:0051249 | 240 | 0.022 | |
| compound eye development | GO:0048749 | 1 | 0.022 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.022 | |
| stem cell fate specification | GO:0048866 | 3 | 0.022 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 167 | 0.021 | |
| regulation of mitotic cell cycle | GO:0007346 | 126 | 0.021 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.021 | |
| male gamete generation | GO:0048232 | 285 | 0.021 | |
| skeletal muscle organ development | GO:0060538 | 163 | 0.021 | |
| monosaccharide metabolic process | GO:0005996 | 106 | 0.020 | |
| regulation of lymphocyte anergy | GO:0002911 | 4 | 0.020 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.020 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 199 | 0.020 | |
| lymphocyte differentiation | GO:0030098 | 242 | 0.020 | |
| reactive oxygen species metabolic process | GO:0072593 | 84 | 0.020 | |
| regulation of histone methylation | GO:0031060 | 30 | 0.020 | |
| regulation of mrna processing | GO:0050684 | 41 | 0.020 | |
| regulation of cell activation | GO:0050865 | 289 | 0.020 | |
| hexose metabolic process | GO:0019318 | 98 | 0.020 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.019 | |
| regulation of t cell activation | GO:0050863 | 170 | 0.019 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.019 | |
| t cell proliferation | GO:0042098 | 120 | 0.019 | |
| histone h4 k16 acetylation | GO:0043984 | 3 | 0.019 | |
| regulation of chromosome organization | GO:0033044 | 83 | 0.019 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.019 | |
| regulation of inflammatory response | GO:0050727 | 147 | 0.019 | |
| regulation of mitotic cell cycle phase transition | GO:1901990 | 73 | 0.019 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.019 | |
| negative regulation of cellular amino acid metabolic process | GO:0045763 | 0 | 0.018 | |
| retrograde transport endosome to golgi | GO:0042147 | 2 | 0.018 | |
| immune effector process | GO:0002252 | 321 | 0.018 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.018 | |
| cellular response to lipid | GO:0071396 | 145 | 0.018 | |
| negative regulation of protein modification process | GO:0031400 | 163 | 0.018 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 226 | 0.018 | |
| nucleoside catabolic process | GO:0009164 | 206 | 0.018 | |
| negative regulation of mitotic cell cycle phase transition | GO:1901991 | 45 | 0.018 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.017 | |
| rna catabolic process | GO:0006401 | 29 | 0.017 | |
| transcription from rna polymerase iii promoter | GO:0006383 | 3 | 0.017 | |
| organic hydroxy compound transport | GO:0015850 | 93 | 0.017 | |
| mrna processing | GO:0006397 | 63 | 0.017 | |
| cellular response to starvation | GO:0009267 | 57 | 0.017 | |
| regulation of histone modification | GO:0031056 | 56 | 0.017 | |
| protein modification by small protein conjugation | GO:0032446 | 187 | 0.017 | |
| norepinephrine transport | GO:0015874 | 2 | 0.017 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.017 | |
| cellular response to nutrient levels | GO:0031669 | 64 | 0.017 | |
| production of molecular mediator of immune response | GO:0002440 | 103 | 0.017 | |
| cellular carbohydrate metabolic process | GO:0044262 | 119 | 0.017 | |
| alpha beta t cell activation | GO:0046631 | 91 | 0.017 | |
| alpha beta t cell differentiation | GO:0046632 | 69 | 0.017 | |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.016 | |
| regulation of cell migration | GO:0030334 | 219 | 0.016 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.016 | |
| cellular response to external stimulus | GO:0071496 | 88 | 0.016 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.016 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.016 | |
| germ cell development | GO:0007281 | 185 | 0.016 | |
| regulation of mrna metabolic process | GO:1903311 | 43 | 0.016 | |
| defense response to other organism | GO:0098542 | 197 | 0.016 | |
| regulation of response to wounding | GO:1903034 | 189 | 0.016 | |
| appendage morphogenesis | GO:0035107 | 149 | 0.016 | |
| habenula development | GO:0021986 | 2 | 0.016 | |
| gonad development | GO:0008406 | 141 | 0.016 | |
| mesenchyme development | GO:0060485 | 152 | 0.016 | |
| regulation of chromatin organization | GO:1902275 | 57 | 0.016 | |
| regulation of interleukin 6 production | GO:0032675 | 55 | 0.016 | |
| placenta development | GO:0001890 | 140 | 0.016 | |
| negative regulation of inflammatory response | GO:0050728 | 61 | 0.016 | |
| canonical wnt signaling pathway | GO:0060070 | 130 | 0.016 | |
| heterochromatin organization | GO:0070828 | 4 | 0.016 | |
| interleukin 6 production | GO:0032635 | 58 | 0.016 | |
| cellular response to organic cyclic compound | GO:0071407 | 87 | 0.016 | |
| protein localization to organelle | GO:0033365 | 185 | 0.015 | |
| somatic stem cell maintenance | GO:0035019 | 47 | 0.015 | |
| regulation of t cell proliferation | GO:0042129 | 92 | 0.015 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.015 | |
| negative regulation of cell development | GO:0010721 | 169 | 0.015 | |
| gland development | GO:0048732 | 330 | 0.015 | |
| myeloid cell homeostasis | GO:0002262 | 114 | 0.015 | |
| regulation of hormone levels | GO:0010817 | 211 | 0.015 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.015 | |
| glycosyl compound catabolic process | GO:1901658 | 206 | 0.015 | |
| negative regulation of cellular amine metabolic process | GO:0033239 | 1 | 0.015 | |
| negative regulation of defense response | GO:0031348 | 77 | 0.015 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.015 | |
| cellular response to extracellular stimulus | GO:0031668 | 81 | 0.015 | |
| regulation of leukocyte proliferation | GO:0070663 | 121 | 0.014 | |
| tube formation | GO:0035148 | 140 | 0.014 | |
| regulation of homeostatic process | GO:0032844 | 182 | 0.014 | |
| negative regulation of cell activation | GO:0050866 | 111 | 0.014 | |
| embryonic placenta development | GO:0001892 | 98 | 0.014 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.014 | |
| endocytosis | GO:0006897 | 168 | 0.014 | |
| positive regulation of purine nucleotide catabolic process | GO:0033123 | 88 | 0.014 | |
| rho protein signal transduction | GO:0007266 | 32 | 0.014 | |
| erythrocyte differentiation | GO:0030218 | 88 | 0.014 | |
| negative regulation of t cell activation | GO:0050868 | 65 | 0.014 | |
| stem cell development | GO:0048864 | 219 | 0.014 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.014 | |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.014 | |
| positive regulation of cytokine production | GO:0001819 | 174 | 0.014 | |
| cardiocyte differentiation | GO:0035051 | 87 | 0.014 | |
| rac protein signal transduction | GO:0016601 | 13 | 0.014 | |
| regulation of blood pressure | GO:0008217 | 93 | 0.014 | |
| leukocyte proliferation | GO:0070661 | 172 | 0.014 | |
| regulation of nuclear transcribed mrna poly a tail shortening | GO:0060211 | 4 | 0.014 | |
| oogenesis | GO:0048477 | 56 | 0.014 | |
| skeletal system morphogenesis | GO:0048705 | 203 | 0.013 | |
| morphogenesis of embryonic epithelium | GO:0016331 | 159 | 0.013 | |
| appendage development | GO:0048736 | 166 | 0.013 | |
| negative regulation of phosphorus metabolic process | GO:0010563 | 184 | 0.013 | |
| carbohydrate biosynthetic process | GO:0016051 | 74 | 0.013 | |
| learning or memory | GO:0007611 | 148 | 0.013 | |
| regulation of protein sumoylation | GO:0033233 | 4 | 0.013 | |
| epithelial tube formation | GO:0072175 | 130 | 0.013 | |
| positive regulation of apoptotic signaling pathway | GO:2001235 | 95 | 0.013 | |
| myotube differentiation | GO:0014902 | 105 | 0.013 | |
| exocytosis | GO:0006887 | 121 | 0.013 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.013 | |
| limb development | GO:0060173 | 166 | 0.013 | |
| camera type eye development | GO:0043010 | 266 | 0.013 | |
| negative regulation of immune effector process | GO:0002698 | 55 | 0.013 | |
| cellular response to biotic stimulus | GO:0071216 | 92 | 0.013 | |
| neural tube development | GO:0021915 | 160 | 0.013 | |
| regulation of synaptic growth at neuromuscular junction | GO:0008582 | 4 | 0.013 | |
| regulation of asymmetric cell division | GO:0009786 | 4 | 0.012 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.012 | |
| artery development | GO:0060840 | 53 | 0.012 | |
| cellular protein catabolic process | GO:0044257 | 155 | 0.012 | |
| demethylation | GO:0070988 | 23 | 0.012 | |
| histone deubiquitination | GO:0016578 | 2 | 0.012 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.012 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.012 | |
| forebrain development | GO:0030900 | 302 | 0.012 | |
| positive regulation of cellular catabolic process | GO:0031331 | 148 | 0.012 | |
| hematopoietic progenitor cell differentiation | GO:0002244 | 143 | 0.012 | |
| positive regulation of chromosome organization | GO:2001252 | 33 | 0.012 | |
| regulation of anatomical structure size | GO:0090066 | 178 | 0.012 | |
| chemotaxis | GO:0006935 | 247 | 0.012 | |
| response to acid chemical | GO:0001101 | 111 | 0.012 | |
| embryonic organ morphogenesis | GO:0048562 | 276 | 0.012 | |
| neural precursor cell proliferation | GO:0061351 | 121 | 0.012 | |
| nuclear transcribed mrna catabolic process deadenylation dependent decay | GO:0000288 | 12 | 0.012 | |
| muscle cell development | GO:0055001 | 133 | 0.012 | |
| regulation of t cell anergy | GO:0002667 | 4 | 0.012 | |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.012 | |
| regulation of protein localization | GO:0032880 | 231 | 0.012 | |
| negative regulation of organelle organization | GO:0010639 | 90 | 0.012 | |
| regulation of protein catabolic process | GO:0042176 | 108 | 0.012 | |
| neuroblast differentiation | GO:0014016 | 2 | 0.012 | |
| pharynx development | GO:0060465 | 1 | 0.012 | |
| purine nucleotide catabolic process | GO:0006195 | 211 | 0.011 | |
| axon guidance | GO:0007411 | 141 | 0.011 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.011 | |
| regulation of rna splicing | GO:0043484 | 37 | 0.011 | |
| regulation of cellular response to stress | GO:0080135 | 159 | 0.011 | |
| adult behavior | GO:0030534 | 135 | 0.011 | |
| t cell anergy | GO:0002870 | 4 | 0.011 | |
| mirna catabolic process | GO:0010587 | 2 | 0.011 | |
| lung development | GO:0030324 | 164 | 0.011 | |
| monosaccharide biosynthetic process | GO:0046364 | 44 | 0.011 | |
| catecholamine secretion | GO:0050432 | 15 | 0.011 | |
| regulation of reactive oxygen species metabolic process | GO:2000377 | 40 | 0.011 | |
| protein ubiquitination | GO:0016567 | 171 | 0.011 | |
| regulation of multi organism process | GO:0043900 | 111 | 0.011 | |
| positive regulation of gtp catabolic process | GO:0033126 | 85 | 0.011 | |
| negative regulation of response to wounding | GO:1903035 | 77 | 0.011 | |
| mitotic cell cycle | GO:0000278 | 195 | 0.011 | |
| regulation of chromatin modification | GO:1903308 | 57 | 0.011 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 205 | 0.011 | |
| development of primary sexual characteristics | GO:0045137 | 143 | 0.011 | |
| respiratory tube development | GO:0030323 | 167 | 0.011 | |
| positive regulation of organelle organization | GO:0010638 | 128 | 0.011 | |
| negative regulation of t cell proliferation | GO:0042130 | 38 | 0.011 | |
| endocrine system development | GO:0035270 | 98 | 0.011 | |
| regulation of nucleotide metabolic process | GO:0006140 | 169 | 0.011 | |
| ribonucleoside catabolic process | GO:0042454 | 206 | 0.011 | |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.011 | |
| myeloid leukocyte differentiation | GO:0002573 | 119 | 0.011 | |
| organelle localization | GO:0051640 | 179 | 0.011 | |
| cellular response to molecule of bacterial origin | GO:0071219 | 83 | 0.011 | |
| synaptic transmission | GO:0007268 | 329 | 0.011 | |
| lymphocyte anergy | GO:0002249 | 4 | 0.011 | |
| nephron epithelium development | GO:0072009 | 92 | 0.011 | |
| chromatin remodeling | GO:0006338 | 32 | 0.011 | |
| histone h4 k20 methylation | GO:0034770 | 8 | 0.011 | |
| regulation of secretion | GO:0051046 | 274 | 0.011 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.011 | |
| nuclear transcribed mrna poly a tail shortening | GO:0000289 | 7 | 0.011 | |
| formation of primary germ layer | GO:0001704 | 77 | 0.010 | |
| response to oxygen radical | GO:0000305 | 16 | 0.010 | |
| mesoderm development | GO:0007498 | 100 | 0.010 | |
| regulation of alpha beta t cell activation | GO:0046634 | 53 | 0.010 | |
| regulation of leukocyte differentiation | GO:1902105 | 159 | 0.010 | |
| blood circulation | GO:0008015 | 195 | 0.010 | |
| somatic diversification of immunoglobulins | GO:0016445 | 43 | 0.010 | |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 199 | 0.010 | |
| lateral inhibition | GO:0046331 | 1 | 0.010 | |
| cell fate commitment | GO:0045165 | 210 | 0.010 | |
| sensory perception | GO:0007600 | 245 | 0.010 | |
| cellular homeostasis | GO:0019725 | 240 | 0.010 | |
| proteasomal protein catabolic process | GO:0010498 | 98 | 0.010 | |
| negative regulation of lymphocyte proliferation | GO:0050672 | 45 | 0.010 | |
| negative regulation of cytokine production | GO:0001818 | 84 | 0.010 | |
| cell fate specification | GO:0001708 | 72 | 0.010 | |
| neuroblast fate commitment | GO:0014017 | 1 | 0.010 | |
| organelle assembly | GO:0070925 | 177 | 0.010 | |
| establishment of organelle localization | GO:0051656 | 122 | 0.010 | |
| regulation of cellular component biogenesis | GO:0044087 | 181 | 0.010 | |
| limb morphogenesis | GO:0035108 | 149 | 0.010 | |
| negative regulation of histone modification | GO:0031057 | 18 | 0.010 | |
